Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
Zidavi is recommended by the Infectious Disease Society of America
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
Subscribe To Our Newsletter & Stay Updated
